The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry

Dr. Ashenden is Senior Artificial Intelligence and Machine Learning Data Scientist at AstraZeneca, working in the Discovery Sciences, IMed-Biotech Unit. She received her PhD in 2018 from the Department of Chemistry, Cambridge University. Dr. Ashenden has three publications, but in very high impact resources (Methods in Enzymology, Journal of Chemical Information and Modeling, and Journal of Medicinal Chemistry). Dr. Ashenden is a very early career researcher, but has an extensive research network, academic and industrial experience, and a drive to conduct and report high quality research. She will be working with more experienced researchers on the project to help guide and offer experience.

1. Introduction Drug Discovery 2. Intro to ML 3. Data Types 4. Target ID and Val 5. Hit Discovery 6. Lead Optimisation 7. Evaluating Safety and Toxicity 8. Precision Medicine and Finding the 'right patient': Date-driven Identification of Disease Subtypes 9. Image Analysis in Drug Discovery 10. Clinical Trials, Real World Evidence and Digital Medicine 11. To and From the Patient